The thymidylate synthase (TYMS), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and methionine synthase reductase (MTRR) are suitable genes to study the role of variants of genes involved in the metabolism of folate in the BC risk. Here, TYMS is linked to breast cancer.